M-A: Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage.
11 Apr, 2022 | 00:52h | UTCProphylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials – Stroke (link to abstract – $ for full-text)
Commentary on Twitter
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials #stroke #AHAJournals https://t.co/GkM5GlFBd7 pic.twitter.com/6ipIaUK5KX
— Stroke AHA/ASA (@StrokeAHA_ASA) April 8, 2022